Advertisement
Screener

HOLOGIC INC Form 8-K: Current report, 2024

HOLOGIC INC Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2024-12-09: Form 8-K; Period of report 2024-12-06; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
  • 2024-11-08: Form 8-K; Period of report 2024-11-05; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
  • 2024-11-04: Form 8-K; Period of report 2024-11-04; Description 2.02 Results of Operations and Financial Condition; Details 2.02.
  • 2024-09-13: Form 8-K; Period of report 2024-09-12; Description 8.01 Other Events; Details 8.01.
FiledFormPeriod of reportDescriptionDetailsDocument
2024-12-098-K2024-12-065.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 On December 6, 2024, the Board of Directors (the “Board”) of Hologic, Inc. (the “Company”), upon the recommendation of the Company’s Nominating and Corporate Governance Committee, increased the size of the Board from nine to ten directors and appointed Martin Madaus as a director of the Company, effective December 6, 2024.ef20039609_8k.htm
2024-11-088-K2024-11-055.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 Approval of revised forms of Performance Stock Unit (“PSU”) Award Agreements.d886274d8k.htm
2024-11-048-K2024-11-042.02 Results of Operations and Financial Condition2.02 On November 4, 2024, Hologic, Inc. issued a press release announcing its financial results for the fourth quarter and year ended September 28, 2024.ef20038078_8k.htm
2024-09-138-K2024-09-128.01 Other Events8.01 On September 12, 2024, the Board of Directors of Hologic, Inc. (the “Company”) authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.5 billion of the Company’s outstanding common stock.ef20035675_8k.htm
2024-07-298-K2024-07-292.02 Results of Operations and Financial Condition2.02 On July 29, 2024, Hologic, Inc. issued a press release announcing its financial results for the third quarter ended June 29, 2024.ef20033179_8k.htm
2024-05-038-K/A2024-05-022.02 Results of Operations and Financial Condition2.02 On May 3, 2024, Hologic, Inc. updated its press release, originally issued on May 2, 2024 (the “Original Release”) announcing its financial results for the second quarter ended March 30, 2024.ef20028431_8ka.htm
2024-05-028-K2024-05-022.02 Results of Operations and Financial Condition2.02 On May 2, 2024, Hologic, Inc. issued a press release announcing its financial results for the second quarter ended March 30, 2024.ef20028283_8k.htm
2024-03-128-K2024-03-075.07 Submission of Matters to a Vote of Security Holders5.07 The Company’s Annual Meeting of Stockholders was held on March 7, 2024.holx-20240307.htm
2024-02-018-K2024-02-012.02 Results of Operations and Financial Condition2.02 On February 1, 2024, Hologic, Inc. issued a press release announcing its financial results for the first quarter ended December 30, 2023.a53890608.htm
2024-01-128-K2024-01-115.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officersa53880546.htm
2024-01-088-K2024-01-072.02 Results of Operations and Financial Condition2.02 On January 7, 2024, Hologic, Inc. issued a press release announcing its preliminary revenue results for the first quarter ended December 30, 2023.a53878061.htm